COL10A1 and Hip dysplasia: In 3-week-old MCDS mice with Col10a1 p.N617K mutation, 3-week CBZ treatment (250 mg/kg/d) significantly reduced the width of the hypertrophic zone, increased femur and tibia growth, and alleviated hip dysplasia [21].